Indicative Announcement on Tax-Related Matters of a Subsidiary
Filed with SSE · · 1 page · Chinese
Summary by 6ix AI
Chengdu Easton Biopharmaceuticals Co., Ltd. has issued an indicative announcement regarding tax-related matters concerning its subsidiary, Tibet Runhe Pharmaceutical Co., Ltd.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Chengdu Easton Biopharmaceuticals Co., Ltd. on 6ix
Earlier from Chengdu Easton Biopharmaceuticals
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on the Achievement of Performance Assessment Targets for the 2nd Lock-up Period of the 2024 Employee Stock Ownership Plan and the Expiry of the Lock-up Period
- Publicity Explanation and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on List of Initially Granted Incentive Objects in the 2026 Restricted Stock Incentive Plan
- Announcement on Initially Repurchasing the Company's Shares through Call Auction
- Announcement on Canceling Some Restricted Stocks in the 2024 Restricted Stock Incentive Plan
Later from Chengdu Easton Biopharmaceuticals
- Announcement on Vesting Results of the 2nd Vesting Period of Those Initially Granted and the 1st Vesting Period of Those Reserved for Grant in 2024 Restricted Stock Incentive Plan
- Announcement on Progress in Repurchasing Shares
- Announcement on Resolutions of the 14th Meeting of the 4th Board of Directors
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on the Voluntary Disclosure of Obtaining Drug Registration Certificate for Remimazolam Besylate for Injection
Follow Chengdu Easton Biopharmaceuticals into a list and get an email when it puts out news.
Follow Chengdu Easton Biopharmaceuticals